×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Press Release

View printer-friendly version
2004 Washington Recipients of Amgen Award for Science Teaching Excellence Announced

THOUSAND OAKS, Calif.--(April 19, 2004--Amgen (NASDAQ:AMGN), the world's largest biotechnology company, has announced the two science teachers in Washington who are this year's recipients of the Amgen Award for Science Teaching Excellence. The Amgen awards honor public or private school science teachers, grades K-12, who demonstrate outstanding science teaching and have a great impact on the lives of their students. Each teacher will receive an unrestricted $10,000 award at a ceremony in Seattle on May 12. For more information on the award, please contact Amgen at the number below. The 2004 winners are:

  • Suzanne Black of Inglemoor High School in Kenmore, Washington

  • Mike Town of Redmond High School in Redmond, Washington

Nominations are solicited every January and a panel of independent judges selects the winners. Judges base their decisions on evidence of the recipients' creativity and effectiveness in the classroom; their application and development of best practices in science education; their motivational ability; and their mastery of the subject matter and instructional skill.

In addition to the Washington program, the Amgen Award for Science Teaching Excellence is granted in California; Colorado; Jefferson County, Kentucky; Boston and Cambridge, Massachusetts; Puerto Rico; and Rhode Island, locations where Amgen has facilities. Amgen has conducted the awards program for teaching excellence for 13 years in the United States.

Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

EDITOR'S NOTE: An electronic version of this news release may be accessed via our web site at www.amgen.com. Visit the Corporate Center and click on Amgen News. Journalists and media representatives may sign up to receive all news releases electronically at time of announcement by filling out a short form in the Amgen News section of the web site.

CONTACT: Amgen, Thousand Oaks
Mary Klem, 805-447-4587